- Trials with a EudraCT protocol (35)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
35 result(s) found for: Fatty Acid Metabolism.
Displaying page 1 of 2.
EudraCT Number: 2007-005531-28 | Sponsor Protocol Number: Urso in Obese | Start Date*: 2008-04-03 | |||||||||||
Sponsor Name:Hanns-Ulrich Marschall | |||||||||||||
Full Title: Ursodeoxycholic Acid in Morbidly Obese Patients Before Bariatric Surgery | |||||||||||||
Medical condition: Patients with morbid obesity (MB) are investigated. MB is very frequently (90%) associated with non-alcoholic fatty liver disease (NAFLD) comprising a spectrum reaching from steatosis (NAFL) over s... | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001975-36 | Sponsor Protocol Number: 201200197536 | Start Date*: 2012-05-24 | |||||||||||
Sponsor Name:AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA | |||||||||||||
Full Title: Evaluation on the efficacy of docosahexaenoic acid for the treatment of nonalcoholic fatty liver disease in children | |||||||||||||
Medical condition: Nonalcoholic steatohepatitis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000813-37 | Sponsor Protocol Number: OCABSGS | Start Date*: 2012-05-16 | |||||||||||
Sponsor Name:Sahlgrenska Academy | |||||||||||||
Full Title: Effects of obeticholic acid on hepatic fatty acid/triglyceride metabolism and hepatobiliary detoxification/elimination in morbidly obese and gallstone patients. | |||||||||||||
Medical condition: Fatty liver disease, morbid obesity, gallstone disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006424-18 | Sponsor Protocol Number: EC/2006/117/PGMS | Start Date*: 2007-03-01 | |||||||||||
Sponsor Name:University of Surrey | |||||||||||||
Full Title: THE EFFECT OF RIMONABANT ON ENERGY EXPENDITURE, FATTY ACID METABOLISM, TRIACYLGLYCEROL METABOLISM AND BODY FAT DISTRIBUTION | |||||||||||||
Medical condition: Obesity | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000367-25 | Sponsor Protocol Number: AURIGA | Start Date*: 2019-04-17 | |||||||||||
Sponsor Name:FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO | |||||||||||||
Full Title: Acute effect of parenteral rehydration solution commonly used in children with acute gastroenteritis on acid-base balance, free-fatty acids metabolism and glucose homeostasis | |||||||||||||
Medical condition: Dehydration and metabolic acidosis due to acute gastroenteritis | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000645-12 | Sponsor Protocol Number: GFT505-219-8 | Start Date*: 2019-09-03 | |||||||||||
Sponsor Name:GENFIT SA | |||||||||||||
Full Title: A Double-Blind, Placebo-Controlled, Cross-over Phase II Study to Evaluate the Effect of a 6-week Elafibranor (120mg) treatment administered once daily on hepatic lipid composition in subjects with ... | |||||||||||||
Medical condition: Subjects with Nonalcoholic Fatty Liver (NAFL) | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011106-42 | Sponsor Protocol Number: 2008MZ09B | Start Date*: 2009-06-25 |
Sponsor Name:Institute for Clinical and Experimental Medicine | ||
Full Title: Aditive effects of omega-3 polyunsaturated fatty acids and pioglitazone in the treatment of type 2 diabetes mellitus | ||
Medical condition: The project deals with hummoral and metabolic aspects of insulin resistance (IR), which is assumed to be the basic metabolic disorder which leads to the development of type 2 diabetes mellitus (T2D... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-002321-74 | Sponsor Protocol Number: 20061218 | Start Date*: 2007-08-29 | |||||||||||
Sponsor Name:Aarhus University Hospital, Skejby sygehus | |||||||||||||
Full Title: Effect of 4 weeks treatment with Acipimox on left ventricular function, work capacity, insulin sensitivity and substrate metabolism in patients with chronic heart failure | |||||||||||||
Medical condition: chronic stable heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003029-11 | Sponsor Protocol Number: 2012-489 | Start Date*: 2012-09-10 | ||||||||||||||||
Sponsor Name:Steen Stender | ||||||||||||||||||
Full Title: Ethyl ester Versus Triglyceride formulations of long chained omega-3 fatty acids in moderate hypertriglyceridemia - a randomized placebo-controlled clinical trial (EVT) | ||||||||||||||||||
Medical condition: Hypertriglyceridemia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000322-19 | Sponsor Protocol Number: UX007-CL202 | Start Date*: 2016-06-06 |
Sponsor Name:Ultragenyx Pharmaceutial Inc. | ||
Full Title: An Open-label Long-Term Safety and Efficacy Extension Study in Subjects with Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Previously Enrolled in UX007 or Triheptanoin Studies | ||
Medical condition: Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: View results |
EudraCT Number: 2013-004830-14 | Sponsor Protocol Number: UX007-CL201 | Start Date*: 2014-02-26 |
Sponsor Name:Ultragenyx Pharmaceutical Inc. | ||
Full Title: An Open-Label Phase 2 Study to Assess Safety and Clinical Effects of UX007 in Subjects with Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) | ||
Medical condition: Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-000808-16 | Sponsor Protocol Number: C11palmitatmetformin | Start Date*: 2013-03-27 | |||||||||||
Sponsor Name:Aarhus University Hospital | |||||||||||||
Full Title: Effects of metformin on hepatic free fatty acid metabolism in type 2 diabetes asssessed by positron emission tomography | |||||||||||||
Medical condition: Type 2 diabetes and dyslipidemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001671-79 | Sponsor Protocol Number: CAIN457ADE08 | Start Date*: 2018-02-15 | |||||||||||
Sponsor Name:Novartis Pharma GmbH | |||||||||||||
Full Title: A randomized, multicenter 28 week study to compare the efficacy and safety of combining Cosentyx (Secukinumab) (4-weekly, 300 mg s.c.) with a lifestyle intervention to Cosentyx therapy alone in adu... | |||||||||||||
Medical condition: Moderate to severe plaque type psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001934-19 | Sponsor Protocol Number: LPS14354 | Start Date*: 2016-02-15 | |||||||||||
Sponsor Name:Sanofi-Aventis Groupe | |||||||||||||
Full Title: A Randomized, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Alirocumab Versus Usual Care in Patients with Type 2 Diabetes and Mixed Dyslipidemia at High Cardiovascular Ris... | |||||||||||||
Medical condition: Dyslipidemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) DE (Completed) GB (Completed) SE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001019-19 | Sponsor Protocol Number: UX007 | Start Date*: 2016-06-27 |
Sponsor Name:LIEGE University Hospital | ||
Full Title: A pilot trial of triheptanoin for the preventive treatment of migraine | ||
Medical condition: Migraine | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-002880-82 | Sponsor Protocol Number: GUARD | Start Date*: 2020-05-05 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: Randomised controlled trial of Gestational treatment with Ursodeoxycholic Acid compared to Metformin to Reduce effects of Diabetes mellitus | |||||||||||||
Medical condition: Gestational Diabetes Mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003511-11 | Sponsor Protocol Number: D5881C00006 | Start Date*: 2015-01-14 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Two-part, Open-label, Randomised, Crossover, Multicentre, Phase II Study to Investigate the Presence of Pancreatic Exocrine Insufficiency (PEI) in Patients with Type 2 Diabetes Mellitus, and to I... | |||||||||||||
Medical condition: Type 2 Diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) SE (Completed) DK (Completed) HU (Completed) LV (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-005028-92 | Sponsor Protocol Number: BC3-CT011 | Start Date*: 2015-01-06 | |||||||||||
Sponsor Name:Adocia | |||||||||||||
Full Title: Blood glucose control with BC222 insulin lispro compared to insulin lispro (Humalog®) after ingestion of a standardised meal. | |||||||||||||
Medical condition: Diabetes mellitus type 1 | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003700-31 | Sponsor Protocol Number: ImNuT | Start Date*: 2017-10-11 |
Sponsor Name:Oslo University Hospital | ||
Full Title: Effects of nutrition therapy on growth, metabolism and inflammation in immature infants; a double-blind randomized, controlled trial | ||
Medical condition: To determine whether early and prolonged supply of ARA and DHA improves quality of growth and clinical outcomes in extreme premature infants as compared to our present nutrient supply. By closely a... | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001979-70 | Sponsor Protocol Number: IVA_01_337_HNAS_16_002 | Start Date*: 2017-01-23 | |||||||||||
Sponsor Name:Inventiva S.A. | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, multicenter, dose-range, proof-of-concept, 24-week treatment study of IVA337 in adult subjects with nonalcoholic steatohepatitis (NASH) | |||||||||||||
Medical condition: Nonalcoholic steatohepatitis (NASH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) CZ (Completed) AT (Completed) PT (Completed) ES (Completed) NL (Completed) PL (Completed) FR (Completed) BG (Completed) SI (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.